RecruitingNCT01731665

Epidemiology of Inflammatory Bowel Disease in the Songpa-Kangdong District, Seoul, Korea.


Sponsor

Asan Medical Center

Enrollment

2,000 participants

Start Date

Dec 1, 2012

Study Type

OBSERVATIONAL

Conditions

Summary

The purpose of this study is to evaluate the incidence, prevalence, clinical characteristics and prognosis of Crohn's disease and ulcerative colitis over time in a district of Seoul, Korea.


Eligibility

Plain Language Summary

Simplified for easier understanding

This study tracks the number of people diagnosed with inflammatory bowel disease (IBD) — specifically Crohn's disease and ulcerative colitis — in a specific district of Seoul, South Korea, to understand how common these conditions are becoming. **You may be eligible if...** - You have been definitively diagnosed with Crohn's disease or ulcerative colitis based on standard medical criteria (symptoms, imaging, biopsies, and scope exams) - You are of Korean ethnicity living in the Songpa-Kangdong district of Seoul **You may NOT be eligible if...** - Your IBD cannot be classified as either Crohn's disease or ulcerative colitis - You are not of Korean ethnic background Talk to your doctor to see if this trial is right for you.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.


Locations(1)

Asan Medical Center

Seoul, South Korea

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT01731665


Related Trials